Core Laboratories
CLB
345 hedge funds and large institutions have $5.07B invested in Core Laboratories in 2017 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 137 increasing their positions, 108 reducing their positions, and 55 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 137 | Existing positions reduced: 108
5.47% more ownership
Funds ownership: 111.02% → 116.49% (+5.5%)
2% more capital invested
Capital invested by funds: $4.97B → $5.07B (+$107M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 360 → 345 (-15)
20% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 55
23% less call options, than puts
Call options by funds: $18.3M | Put options by funds: $23.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$172M |
| 2 |
State Street
Boston,
Massachusetts
|
+$63.6M |
| 3 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$40.4M |
| 4 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$35.3M |
| 5 |
Bank of New York Mellon
New York
|
+$32.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$75.6M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$63.4M |
| 3 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
-$53.5M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$49.2M |
| 5 |
AC
AKO Capital
London,
United Kingdom
|
-$31.4M |
CLB Hedge Fund Activity: Q3 2017 in Review
345 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q3 2017, worth a combined $5.07B — up 2.2% from $4.97B a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of CLB and 44 opened new positions — a net loss of 11 holders — while 108 trimmed existing stakes and 137 added.
The largest buyer was BlackRock, adding an estimated $172M. The largest seller was Millennium Management, exiting entirely with an estimated $75.6M sold.
- 345 institutional investors held Core Laboratories (CLB) as of Q3 2017, down from 360 in Q2 2017.
- Funds reported $5.07B of Core Laboratories stock for Q3 2017, up 2.2% quarter-over-quarter.
- 44 funds opened new Core Laboratories positions in Q3 2017 and 55 closed out, a net change of -11 holders.
- The largest Core Laboratories buyer in Q3 2017 was BlackRock, an estimated $172M added.
- The largest Core Laboratories seller in Q3 2017 was Millennium Management, an estimated $75.6M sold.
Based on aggregated 13F filings for Q3 2017.